Funding for this research was provided by:
National Institute on Aging (R03AG051071)
National Institutes of Health (R21AG056883, R01AG046619)
U.S. Department of Veterans Affairs
NIH (P50AG005136, U01 AG006781, UL1 TR002319)
Received: 18 May 2020
Accepted: 9 September 2020
First Online: 29 September 2020
Ethics approval and consent to participate
: De-identified human brain issues are provided by the University of Washington Alzheimer’s Disease Research Center and the Adult Changes in Thought Study.
: Not applicable.
: Anthony J. Day is a Director of Link Biologics, which is focused on the use of a TSG-6-based biological drug for inflammatory conditions. The other authors have no conflict of interest to report.